English
-
COVID-19 Community Resource
COVID-19 has revealed – and drastically worsened – economic and social inequality on a global scale. Governmental decisions to prioritize...
-
Utilizing TRIPS flexibilities – Kenya and Uganda
This policy brief follows on from research into the impact of patents on the price and availability of essential medicines...
-
Advancing access to medicines in Kenya and Uganda
Research, carried out in partnership by MMA partners in Uganda (CEHURD) and Kenya (KELIN), assessed the impact patents have on...
-
Thailand: Roles required to increase access to HIV services during COVID-19
Due to the COVID-19 lockdown policy, people living with HIV in Thailand were unable to access HIV-related services and ARVs...
-
TB Community Resource
The world has the tools, targets and a plan to eliminate tuberculosis (TB), which is the world’s deadliest infectious disease...
-
Hepatitis C (HCV) Community Resource
Although the world has the tools – and a plan – to eliminate hepatitis C virus (HCV), it remains a...
-
Evergreening patents in Ukraine
The research analyzes 132 patents for the most important life-saving medicines in Ukraine on whether they can be considered as...
-
Why Ukraine needs a Patent Reform for Medicinal Products
Ukraine’s reformed patent law came into effect in August 2020. Read the public health arguments that are relevant and can...
-
The concept of Compulsory Licensing (CL)
The Concept of Implementing a Compulsory Licensing Mechanism in the public Health Sector in Ukraine. A tool for treatment activists...
-
TRIPS-plus analysis Ukraine
A report on the legal analysis of TRIPS-plus provisions in Ukraine. A look at the legal framework and opportunities for...
-
Analysis of Ukraine’s single-source drug market
Report on the analysis of the single-source drugs market in Ukraine. A useful tool for treatment activists, and which can...
-
Analysis: ARV procurement, Russia 2019
ITPC-ru’s 10th year of community-monitoring and analysis in the Russian Federation.
